Physician profile
Colton Bachman
NPI 1164996369
$2,714.48
in general payments reported to CMS, 2019-2025
26 companies · $715 in 2025
The $715 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $162 · 2022: $191 · 2023: $792 · 2024: $854 · 2025: $715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,361.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $682.79 | 2023-2025 | Speedicath |
| Abbvie INC. | $678.68 | 2023-2025 | |
| Janssen Scientific Affairs, LLC | $234.38 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $205.20 | 2023-2025 | Gemtesa, Orgovyx |
| Photocure INC | $156.21 | 2025 | Cysview |
| Olympus America INC. | $79.46 | 2025 | Itind System |
| C. R. Bard, INC. & Subsidiaries | $74.85 | 2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Innovation Technologies INC | $64.53 | 2024-2025 | Irrisept |
| Pfizer INC. | $62.48 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $55.48 | 2024-2025 | Keytruda, Welireg |
| Rochester Medical Corporation | $55.00 | 2021-2022 | |
| Urogen Pharma, INC. | $53.89 | 2023-2024 | Jelmyto |
| Antares Pharma, INC. | $46.29 | 2024-2025 | Xyosted |
| Medtronic, INC. | $37.38 | 2022-2025 | Interstim |
| Janssen Biotech, INC. | $33.50 | 2023 | Erleada |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $26.99 | 2021 | |
| 180 Medical, INC. | $22.59 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.78 | 2023 | |
| Abc Home Medical Supply, INC. | $20.59 | 2024 | |
| Mission Pharmacal Company | $19.99 | 2023 | Uribel |
| Endo USA, INC. | $16.56 | 2025 | Aveed, Xiaflex |
| Ferring Pharmaceuticals INC. | $16.37 | 2024 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $12.75 | 2023 | Pylarify |
| Hollister Incorporated | $12.53 | 2022 | |
| Laborie Medical Technologies Corp. | $12.25 | 2025 | |
| Teleflex LLC | $11.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colton Bachman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.